Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Corcept Therapeutics (CORT) over the last 10 years, with Q3 2025 value amounting to $120.0 million.

  • Corcept Therapeutics' Shares Outstanding (Diluted Average) rose 550.28% to $120.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.0 million, marking a year-over-year increase of 550.28%. This contributed to the annual value of $113.5 million for FY2024, which is 155.54% up from last year.
  • As of Q3 2025, Corcept Therapeutics' Shares Outstanding (Diluted Average) stood at $120.0 million, which was up 550.28% from $120.5 million recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $129.7 million in Q1 2021 and a low of $109.9 million during Q1 2024
  • For the 5-year period, Corcept Therapeutics' Shares Outstanding (Diluted Average) averaged around $117.6 million, with its median value being $115.4 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first plummeted by 1128.34% in 2022, then surged by 901.06% in 2025.
  • Quarter analysis of 5 years shows Corcept Therapeutics' Shares Outstanding (Diluted Average) stood at $126.0 million in 2021, then fell by 7.94% to $116.0 million in 2022, then fell by 3.64% to $111.7 million in 2023, then increased by 1.56% to $113.5 million in 2024, then grew by 5.73% to $120.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $120.0 million in Q3 2025, compared to $120.5 million in Q2 2025 and $119.8 million in Q1 2025.